Aspira Women’s Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023
31 July 2023 - 10:00PM
Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based
women’s health company focused on the development of gynecologic
disease diagnostic tools, today announced that the company will
report its financial results for the three months ended June 30,
2023 on Monday, August 14, 2023. Management will host a conference
call to discuss financial results and provide a corporate update at
4:30 pm Eastern Time. Details for the call are as follows:
Conference call & Webcast Details: |
Date: |
Monday, August 14 |
Time: |
4:30 pm Eastern Time |
Toll Free: |
1-877-407-4018 |
International: |
1-201-689-8471 |
Webcast: |
Click HERE |
A replay of the webcast will be available on the Events &
Presentation page of the Aspira Women’s Health Investor Relations
website.
About Aspira Women’s Health Inc.Aspira Women’s
Health is transforming women’s gynecological health with the
discovery, development, and commercialization of innovative testing
options for women of all races and ethnicities, starting with
ovarian cancer.
Our ovarian cancer risk assessment portfolio is marketed to
healthcare providers as OvaSuiteSM. OvaWatchSM is a
non-invasive, blood-based test intended for use in the initial
clinical assessment of ovarian cancer risk in women with benign or
indeterminate adnexal masses for which surgical intervention may be
either premature or unnecessary. With a negative predictive value
(NPV) of 99%, OvaWatch allows physicians to confidently rule out
ovarian cancer malignancy and choose the appropriate clinical
management for the right patient at the right time.
Ova1Plus® combines our FDA-cleared products, Ova1® and
Overa®, to detect risk of ovarian malignancy in women with adnexal
masses planned for surgery.
EndoCheck™, Aspira’s first-of-its-kind non-invasive diagnostic
test for endometriosis, is currently in development. Visit our
website for more information
at www.aspirawh.com.
Investor Relations
Contact:Monique Kosse Managing DirectorLifeSci Advisors,
LLCTel: 212-915-3820
Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From Apr 2024 to May 2024
Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From May 2023 to May 2024